| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0074 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |